Search results
Earnings call: Bavarian Nordic sees demand rise for travel vaccines By Investing.com
Investing.com· 21 hours agoIn the first quarter, Bavarian Nordic experienced a surge in demand for its travel health portfolio,...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoThe RS Rating is a 1-99 measure of a stock's 12-month performance. This means Moderna stock outranks...
Public school, religious instruction: Many San Diego County charter school students are also...
U-T San Diego· 3 hours agoIn San Diego County and across California, some K-12 school students are getting what their families...
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 4 days agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WFRV 5 Green Bay· 2 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...
Ozempic or Bust
The Atlantic· 4 days agoIn the early spring of 2020, Barb Herrera taped a signed note to a wall of her bedroom in Orlando, Florida, just above her pillow. Barb was nearly 60...
'Outgoing' boy left in a wheelchair and 'seeing monsters' after chickenpox bout
The US Sun· 4 days agoA DEVASTATED mum claims her son’s childhood has been “destroyed” after he suffered brain damage from...
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Motley Fool via Yahoo Finance· 4 days agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
Dow Jones Today: Dow Extends Winning Streak to Eight Days as Major Indexes Gain For Third...
Investopedia· 2 days agoThe manufacturer of scales and other precision instruments topped sales and profit estimates,...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...